Search

An abstract of the article "Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment," by W. K. Seto and colleagues is presented.

An abstract of the article "Efficacy of 2years of entecavir plus adefovir therapy in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analog treatment," by X. Wang and colleagues is presented.

An abstract of the article "Safety of treatment with nucleoside/nucleotide analogues in chronic hepatitis B: Evaluation of ten-year period," by H. Bodur and colleagues is presented.

The article presents two case studies of two men diagnosed with chronic hepatitis B virus infection after administering imatinib for their chronic myelogenous leukemia.

An abstract of the article "Emergence of entecavir genotypic resistance in a nucleoside naive chronic hepatitis B patient who had been treated for nearly five years: a case report," by F. Liu and colleagues is presented.

An abstract of the article "Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis," by T. Tieghi and colleagues is presented.

An abstract of the article "A case of acquired Fanconi's syndrome and hypophosphatemic osteomalacia induced by prolonged adefovir therapy for chronic hepatitis B," by K. Ishikawa and colleagues is presented.

The article presents a case study of a 67-year old man who developed a fatal reactivation of chronic hepatitis B after withdrawal of lamivudine and tenofovir.

An abstract of the article "A case of drug eruption caused by Abraxane," by R. Manabe and colleagues is presented.

The article describes the case of a 61-year-old man who developed Fanconi's syndrome during treatment with adefovir dipivoxil for chronic hepatitis B. After the patient started receiving the drug, his serum alkaline phosphatase level increased while his bone mineral density decreased, in addition to developing slight kidney damage and renal glycosuria. He was switched to entecavir and was successfully treated with vitamin D, vitamin K and bisphosphonate.

The article presents case studies of two men with chronic hepatitis B, who developed acute liver failure after their withdrawal of adefovir or lamivudine, in which one led to hepatorenal syndrome.

An abstract of a case study "Superficial venous thromboplebitis associated with pegylated interferon alpha-2a treatment in a patient with chronic hepatitis B," by M. Kalafateli and colleagues is presented.

The article describes the case of a 25-year-old man who received bleomycin for testicular seminoma but developed exacerbation of chronic hepatitis B after treatment.

The article describes the case of a 52-year-old woman who received adefovir for chronic hepatitis B but developed acquired Fanconi syndrome during treatment.